Pricing Log in Create free account

Insight Molecular Diagnostics Inc. (IMDX) vs Precipio, Inc. (PRPO)

Insight Molecular Diagnostics Inc. and Precipio, Inc. are both Diagnostics & Research companies. Insight Molecular Diagnostics Inc. is the larger, with a market value of $100.1M against $40.4M — 2.5× the size. Precipio, Inc. grew revenue faster over the last twelve months: 28.0% against −60.8%. Precipio, Inc. has the higher net margin (−4.47% vs −2,955.6%) and the lower return on invested capital (−7.63% vs 0.00%). Across the 17 metrics below, Precipio, Inc. leads on 12 and Insight Molecular Diagnostics Inc. on 5.

Valuation

Metric IMDX PRPO Diagnostics & Research median
P/E n/m n/m 35.56
P/S 66.24 1.41 4.37
P/B n/m 2.59 3.06
Price to free cash flow n/m 48.43 35.76
EV/EBITDA n/m 122.01 24.35
EV/Sales 55.72 1.33 5.51
Earnings yield (49.50%) (2.99%) (1.89%)
Free cash flow yield (28.02%) 2.06% (0.15%)

Profitability

Metric IMDX PRPO Diagnostics & Research median
Gross margin 48.32% 44.11% 50.89%
Operating margin (3,011.86%) (5.68%) (8.57%)
Net margin (2,955.63%) (4.47%) (6.37%)
Free cash flow margin (1,856.23%) 2.90% 0.00%
Return on equity 488.68% (8.98%) (2.92%)
Return on assets (123.46%) (6.05%) (6.71%)
Return on invested capital 0.00% (7.63%) 0.00%

Growth

Metric IMDX PRPO Diagnostics & Research median
Revenue growth (TTM) (60.77%) 28.04% 7.69%
EPS growth (last fiscal year) 64.59% 92.15% 25.92%
Revenue growth, 5-year CAGR 27.24% 31.60% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMDX PRPO Diagnostics & Research median
Debt to equity (0.04) 0.07 0.11
Current ratio 2.00 1.77 2.02
Net debt to EBITDA (0.67) (3.30) 0.70

Dividend

Metric IMDX PRPO Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric IMDX PRPO Diagnostics & Research median
Market cap 100.14m 40.35m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack